Emergency Medicine Doctors in Quincy, MA Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Mrs. Cheri Nicole Melsaether Weaver, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Quincy, MA 02169 Phone: 617-376-5549

Christina L Moreau, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Attn Emergency Dept, Quincy, MA 02169 Phone: 617-376-5549    Fax: 617-376-5553

Ms. Karyn Marie Ridgeway, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell Street, Quincy, MA 02169 Phone: 617-773-6120

Robert G. Dart, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Attn: Emergency Dept, Quincy, MA 02169 Phone: 617-376-5549    Fax: 617-376-5553

Dr. Sarah Marie Stuppy Lawson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Quincy, MA 02169 Phone: 617-376-5533

Stephen P. Mcelroy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Attn Emergency Dept, Quincy, MA 02169 Phone: 617-376-5549    Fax: 617-376-5553

Robert P Perry, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Whitwell St, Attn Emergency Dept, Quincy, MA 02169 Phone: 617-376-5549    Fax: 617-376-5553

Anna Sinclair, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 114 Whitwell St, Attn Emergency Dept, Quincy, MA 02169 Phone: 617-376-5549    Fax: 617-376-5553

News Archive

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

Researchers from NanoBio Corporation and the University of Michigan Medical School today announced the receipt of a $1.5 million grant from the Department of Defense (DoD) to study the use of nanoemulsion-based therapies for protection against burn and wound infections.

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

PRISM technique as accurate as ELISAs in identifying proteins within biological samples

Combining two well-established analytic techniques and adding a twist identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report this week in Proceedings of the National Academy of Sciences Early Edition online.

Mortality risk high among diabetes patients with prior CV events

Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report.

Seven physicians receive ASTRO grants to advance radiation oncology research

The American Society for Radiation Oncology has selected seven leading physicians to receive a total of $675,000 in awards and grants to advance radiation oncology research. The ASTRO Junior Faculty Career Research Training Award, the ASTRO Residents/Fellows in Radiation Oncology Research Seed Grant and the ASTRO/Radiation Oncology Institute Comparative Effectiveness Research Award will fund studies in radiation and cancer biology, radiation physics, translational research, outcomes/health services research and comparative effectiveness research within radiation oncology.

Read more Medical News

› Verified 1 days ago